Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...

Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...

Kiniksa (KNSA) shifts from survival to growth as Arcalyst nears blockbuster sales and pipeline KPL-387 readouts loom—get the ...

By CH Unnikrsihnan Drug maker and researcher Glenmark Pharmaceuticals Ltd's new biological drug candidate Bi-Specific ...

More than 140 U.S. medical organizations are advocating for the passage of a bill that would increase NIH funding for fiscal ...

However, I see one "dark spot" in this acquisition. Merus's operating loss was $110.4 million in Q2, up 82.4% year-over-year, which will ultimately slow Genmab's EPS growth until at least 2028.

Get all latest & breaking news on Nipah Virus. Watch videos, top stories and articles on Nipah Virus at moneycontrol.com.

In this randomized controlled trial involving pediatric patients, fremanezumab led to greater reductions in the number of migraine days per month versus placebo, consistent with previous trials in ...

NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.

In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 23 scientific posters at Maui Derm ...

Kamini Walia, senior scientist at ICMR (Indian Council of Medical Research), explains how the overuse of antibiotics is ...